G. Anantharamaiah

发表

The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction

S. Prabhu, T. Hamid, M. A. Ismahil, 2020, International journal of molecular sciences.

Effects of ApoA-I Mimetic Peptide L-4F in LPS-Mediated Inflammation

H. Gupta, O. F. Sharifov, G. Anantharamaiah, 2015 .

Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis

A. Gaggar, W. Grizzle, H. Gupta, 2013, PloS one.

Regulation of Pattern Recognition Receptors by the Apolipoprotein A-I Mimetic Peptide 4F

Molecular Genetics, D. Crossman, C. White, 2012, Arteriosclerosis, thrombosis, and vascular biology.

HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

H. Gupta, C. White, G. Anantharamaiah, 2011, Journal of clinical & experimental cardiology.

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

J. M. Wyss, H. Gupta, Rakesh P. Patel, 2010, Journal of Lipid Research.

Inhibition of Lipopolysaccharide-Induced Inflammatory Responses by an Apolipoprotein AI Mimetic Peptide

W. A. Bradley, H. Gupta, V. Mishra, 2005, Circulation research.

The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.

C. White, G. Anantharamaiah, L. Wilson, 2019, Chemistry and physics of lipids.

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.

A. Mendez, G. Anantharamaiah, J. Segrest, 1994, The Journal of clinical investigation.

Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F

A. Buck, C. White, G. Anantharamaiah, 2012, Journal of Lipid Research.

High-density lipoprotein: Antioxidant and anti-inflammatory properties

S. Reddy, N. Gharavi, M. Navab, 2007, Current atherosclerosis reports.

High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.

C. White, G. Anantharamaiah, S. Giordano, 2016, Chemistry and physics of lipids.

Novel method for reducing plasma cholesterol: a ligand replacement therapy

G. Anantharamaiah, D. Goldberg, 2015, Clinical lipidology.

[36] Synthetic peptide analogs of apolipoproteins

G. Anantharamaiah, 1986 .

Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model.

S. Reddy, H. Herschman, Martín G. Martín, 2019, The Journal of clinical investigation.

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia

C. White, G. Anantharamaiah, P. Wolkowicz, 2021, Biomolecules.

Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.

V. Mishra, G. Anantharamaiah, M. Palgunachari, 2013, Atherosclerosis.

Synthetic peptides: managing lipid disorders

S. Reddy, H. Gupta, J. Segrest, 2006, Current opinion in lipidology.

Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention

S. Reddy, M. Navab, A. Fogelman, 2006, Nature Clinical Practice Cardiovascular Medicine.

Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A

H. Gupta, O. F. Sharifov, G. Anantharamaiah, 2014, Innate immunity.

Oral D-4F Causes Formation of Pre-βHigh-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice

S. Reddy, M. Navab, S. Hama, 2004, Circulation.

Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine

R. Schelonka, D. Holt, C. Killingsworth, 2009, Laboratory Investigation.

Pre-β-HDL stimulates placental lactogen release from human trophoblast cells.

S. Handwerger, T. Siddiqi, G. Anantharamaiah, 1999, American journal of physiology. Endocrinology and metabolism.

Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).

H. Gupta, C. White, G. Anantharamaiah, 2010, Atherosclerosis.

Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.

G. Anantharamaiah, I. Aslan, G. Datta, 2003, Atherosclerosis.

Recent progress in the development of apoA–I and apoE mimetic therapies

G. Anantharamaiah, D. Garber, 2013 .

"Compared to the native proteins, apolipoprotein mimetic peptides are inexpensive and worthy of further clinical evaluation, especially since recent investigations have demonstrated that these can be produced as an orally active food supplement."

G. Anantharamaiah, 2013 .

Chromatographic methods for quantitation of apolipoprotein A-I.

G. Anantharamaiah, D. Garber, 1996, Methods in enzymology.

Multiple indications for anti-inflammatory peptides

S. Reddy, M. Navab, A. Fogelman, 2010 .

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides Published, JLR Papers in Press, June 14, 2007.

S. Reddy, J. Segrest, M. Navab, 2007, Journal of Lipid Research.

Apolipoprotein E Mimetics and Cholesterol-Lowering Properties

H. Gupta, O. F. Sharifov, V. Mishra, 2011, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Apolipoprotein E Mimetic Peptides: Cholesterol-Dependent and Cholesterol-Independent Properties

G. Anantharamaiah, D. Garber, D. Goldberg, 2015 .

Apolipoprotein E Mimetic Peptide Dramatically Lowers Plasma Cholesterol and Restores Endothelial Function in Watanabe Heritable Hyperlipidemic Rabbits

W. A. Bradley, H. Gupta, C. White, 2005, Circulation.

Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells Published, JLR Papers in Press, August 1, 2004. DOI 10.1194/jlr.M400251-JLR200

G. Anantharamaiah, N. Dashti, G. Datta, 2004, Journal of Lipid Research.

Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques[S]

E. Morrel, S. Appt, C. White, 2018, Journal of Lipid Research.

Sustained-delivery of an apolipoproteinE-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels

G. Anantharamaiah, D. Garber, N. Katre, 2002 .

HDL Mimetic Peptides

G. Anantharamaiah, C. White, G. Anantharamaiah, 2010 .

Cholesterol reduction and macrophage function: role of paraoxonases

C. White, G. Anantharamaiah, 2017, Current opinion in lipidology.

ApoA-I Mimetic Peptides with Differing Ability to Inhibit Atherosclerosis Also Exhibit Differences in Their Interactions with Membrane Bilayers*

A. D. Bain, D. Hughes, R. Epand, 2007, Journal of Biological Chemistry.

L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils

A. Gaggar, H. Gupta, O. F. Sharifov, 2014, Inflammation.

Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats.

Andrew P. Miller, J. Chatham, C. White, 2009, American journal of physiology. Heart and circulatory physiology.

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice[S]

R. Epand, R. Epand, V. Mishra, 2010, Journal of Lipid Research.

Two Homologous Apolipoprotein AI Mimetic Peptides

R. Epand, R. Epand, G. Anantharamaiah, 2004, Journal of Biological Chemistry.

Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1 Published, JLR Papers in Press, October 6, 2005.

A. Vaughan, G. Anantharamaiah, J. Oram, 2006, Journal of Lipid Research.

Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.

Philip A. Kramer, S. Ballinger, D. Crossman, 2015, The Biochemical journal.

Lipoprotein Modulation of Proteinuric Renal Injury

I. Pastan, T. Ikizler, M. Linton, 2019, Laboratory Investigation.

Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.

V. Mishra, G. Anantharamaiah, M. Palgunachari, 2012, Atherosclerosis.

Synthetic peptide analogs of apolipoproteins.

G. Anantharamaiah, 1986, Methods in enzymology.

Structural and biological studies on synthetic peptide analogues of a low-affinity calcium-binding site of skeletal troponin C.

G. Anantharamaiah, H. Cheung, A. Gawish, 1987, Biochimica et biophysica acta.

The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

A. Chait, S. Pennathur, J. Brunzell, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.

C. White, G. Anantharamaiah, L. Smythies, 2010, American journal of physiology. Cell physiology.

Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).

H. Gupta, C. White, G. Anantharamaiah, 2009, Vascular disease prevention.

HDL therapy for cardiovascular diseases: the road to HDL mimetics

H. Gupta, V. Mishra, C. White, 2008, Current atherosclerosis reports.

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review

C. White, G. Anantharamaiah, D. Garber, 2014, Journal of Lipid Research.

Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease

T. Groen, I. Kadish, G. Anantharamaiah, 2009, Neurobiology of Disease.

Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides

R. Shin, J. Segrest, V. Mishra, 2012, Journal of Lipid Research.

Influenza Infection Promotes Macrophage Traffic Into Arteries of Mice That Is Prevented by D-4F, an Apolipoprotein A-I Mimetic Peptide

M. Fishbein, G. Anantharamaiah, D. Nayak, 2002, Circulation.

ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch’s Membrane and Causes Its Structural Remodeling

C. Curcio, M. Rudolf, J. Messinger, 2018, Current eye research.

Potential clinical utility of high-density lipoprotein-mimetic peptides

S. Reddy, G. Anantharamaiah, M. Navab, 2006, Current opinion in lipidology.

Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats.

H. Gupta, S. Litovsky, V. Mishra, 2013, Biochemical and biophysical research communications.

L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.

Feng Su, S. Reddy, R. Farias-Eisner, 2011, Integrative biology : quantitative biosciences from nano to macro.

Atherosclerosis and vascular disease: effects of peptide mimetics of apolipoproteins.

H. Gupta, V. Mishra, C. White, 2006, Current pharmaceutical biotechnology.

Extracorporeal Membrane Oxygenation Causes Loss of Intestinal Epithelial Barrier in the Newborn Piglet

C. Killingsworth, G. Anantharamaiah, A. Maheshwari, 2010, Pediatric Research.

In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology.

T. van Groen, I. Kadish, G. Anantharamaiah, 2013, Journal of Alzheimer's disease : JAD.

Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.

C. White, G. Anantharamaiah, D. Garber, 2016, Protein and peptide letters.

Recent developments in modulating atherogenic lipoproteins

C. White, G. Anantharamaiah, D. Goldberg, 2015, Current opinion in lipidology.

Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity.

G. Anantharamaiah, A. Balasubramaniam, J. Harmony, 1995, Biochemistry.

ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.

H. Gupta, C. White, G. Anantharamaiah, 2010, Advances in experimental medicine and biology.

Sustained-delivery of an apolipoprotein E-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels.

G. Anantharamaiah, D. Garber, N. Katre, 2002, Journal of controlled release : official journal of the Controlled Release Society.

D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice[S]

S. Reddy, M. Navab, A. Fogelman, 2012, Journal of Lipid Research.

L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils

A. Gaggar, H. Gupta, C. White, 2014, Inflammation.

Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model.

A. Fogelman, G. Anantharamaiah, V. Grijalva, 2019, The Journal of clinical investigation.

High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.

G. Anantharamaiah, S. Giordano, C. R. White, 2016, Chemistry and physics of lipids.

Oral amphipathic peptides as therapeutic agents

S. Reddy, G. Anantharamaiah, M. Navab, 2006, Expert opinion on investigational drugs.

Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.

V. Mishra, G. Anantharamaiah, M. Palgunachari, 2013, Atherosclerosis.

The Apolipoprotein E Mimetic Peptide AEM-2 Attenuates Mitochondrial Injury And Apoptosis In Human THP-1 Macrophages.

C. White, G. Anantharamaiah, P. Wolkowicz, 2018, Current topics in peptide & protein research.

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

H. Gupta, G. Anantharamaiah, Jaideep Honavar, 2010, Journal of Lipid Research.

Apolipoprotein Mimetics in the Management of Human Disease

G. Anantharamaiah, D. Goldberg, 2015 .